Drug-Phospholipid Complexa Go Through Strategy for Enhanced Oral Bioavailability

被引:83
作者
Kuche, Kaushik [1 ]
Bhargavi, Nallamothu [1 ]
Dora, Chander Parkash [1 ]
Jain, Sanyog [1 ]
机构
[1] NIPER, Dept Pharmaceut, Ctr Pharmaceut Nanotechnol, Sec 67, Sas Nagar 160062, Punjab, India
关键词
oral bioavailability; phospholipid; drug-phospholipid complex; characterization; SOLID LIPID NANOPARTICLES; WATER-SOLUBLE DRUGS; IN-VIVO; THERAPEUTIC-EFFICACY; PHYSICOCHEMICAL CHARACTERIZATION; DELIVERY-SYSTEMS; FATTY-ACIDS; ABSORPTION; VITRO; DISSOLUTION;
D O I
10.1208/s12249-018-1252-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Among many, the oral route of delivery is considered to be the most favorable route with the highest patient compliance. The main issue with oral delivery is the environmental vulnerability of gastro intestinal tract (G.I.T). The bioavailability could further decrease when drug has poor aqueous solubility and permeability through biological membrane. This drawback could be resolved by employing drug-phospholipid complex strategy, as they utilize mechanism which is similar to the absorption mechanism of nutritional constituents form G.I.T. The drug-phospholipid complexes are considered ideal for oral delivery as they are biodegradable and non-toxic, which enable them to be employed as solubilizer, emulsifier, and as a matrix forming excipient for dugs with poor solubility and/or permeability. The present review compiles the basic know how about the phospholipids and the mechanism through which it improves the bioavailability of drugs. Further, it also compiles the crucial formulation aspects and methods of preparations of drug-phospholipid complex along with its physical and in silico characterization techniques. The increase in number of recent reports involving the utilization of drug-phospholipid complex to improve oral bioavailability of drugs thus explains how vital the strategy is for a successful oral delivery.
引用
收藏
页数:13
相关论文
共 81 条
[1]   MECHANISM OF INTERACTION OF CERTAIN FLAVONOIDS WITH PHOSPHATIDYLCHOLINE OF CELLULAR MEMBRANES [J].
Afanas'eva, Yu. G. ;
Fakhretdinova, E. R. ;
Spirikhin, L. V. ;
Nasibullin, R. S. .
PHARMACEUTICAL CHEMISTRY JOURNAL, 2007, 41 (07) :354-356
[2]   HERBAL REMEDIES FOR TREATMENT OF HYPERTENSION [J].
Agrawal, Manish ;
Nandini, D. ;
Sharma, Vikas ;
Chauhan, N. S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (05) :1-21
[3]  
Alexander A., 2011, INT J APPL BIOL PHAR, V2, P434
[4]   Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) [J].
Andonova, Velichka ;
Peneva, Petya .
CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) :6630-6642
[5]  
[Anonymous], SCIENCE
[6]   Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium [J].
Beg, Sarwar ;
Raza, Kaisar ;
Kumar, Rajendra ;
Chadha, Renu ;
Katare, O. P. ;
Singh, Bhupinder .
RSC ADVANCES, 2016, 6 (10) :8173-8187
[7]   An Exhaustive Review on Recent Advancement in Pharmaceutical Bioadhesive Used for Systemic Drug Delivery Through Oral Mucosa for Achieving Maximum Pharmacological Response and Effect [J].
Behra, Ajay ;
Giri, Tapan Kumar ;
Tripathi, Dulal Krishna ;
Ajazuddin ;
Alexander, Amit .
INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2012, 8 (05) :283-305
[8]  
Bhingare U, 2014, INT J PHARM RES ALLI, V3, P14
[9]   CHARACTERISTICS OF MIXED MICELLAR SOLUTIONS WITH PARTICULAR REFERENCE TO BILE [J].
CAREY, MC ;
SMALL, DM .
AMERICAN JOURNAL OF MEDICINE, 1970, 49 (05) :590-&
[10]   Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs [J].
Cerpnjak, Katja ;
Zvonar, Alenka ;
Gasperlin, Mirjana ;
Vrecer, Franc .
ACTA PHARMACEUTICA, 2013, 63 (04) :427-445